Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

L-ornithine l-aspartate manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Switzerland

Clear all

1 products found

l-ornithine l-aspartate + magnesium aspartate tetrahydrate

Sachets 5 g + 2.4 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #17481
One of the biggest pharmaceutical giants who are known to be delivering first-quality pharmaceutical solutions for an extended period. The line of business includes pharmaceutical manufacturing, fabricating, and processing of drugs for both human as well as veterinary usage.

Manufacturer usually replies in 8 days

L-ornithine L-aspartate Manufacturers

L-ornithine L-aspartate is a medicine for people with advanced liver disease with reduced brain function. Research conducted on L-ornithine-L-aspartate efficacy showed that it can reduce symptoms of reducing brain function in people with a liver disease called cirrhosis. However, L-ornithine-L-aspartate might not help control symptoms hepatic encephalopathy, which were caused by some other reason. L-ornithine-L-aspartate also helps improve athletic performance. L-ornithine-L-aspartate is a combination of two amino acids, ornithine and aspartic acid. While the body uses amino acids as building blocks to make protein, L-ornithine L-aspartate is not used to make protein. The human body instead brakes it down in to get ornithine and aspartic acid. Merz pharma in Germany first filed for a patent and was granted around 2010. Evonik industries and some Japanese companies have also filed for patents for different preparations of these medicines. Most frequently prescribed for impaired brain function in adults with severe liver disease (hepatic encephalopathy). There isn't any solid scientific data to back up its usage for cirrhosis, enhancing athletic performance, or any other conditions. According to research, administering L-ornithine-L-aspartate orally or intravenously to cirrhotic patients may lower their risk of passing away. However, not all studies concur. To determine whether L-ornithine-L-aspartate can benefit those who have cirrhosis, more research is required. If administered intravenously, L-ornithine-L-aspartate is possibly safe. Some patients receiving injections of L-ornithine-L-aspartate have experienced nausea, vomiting, coughing, muscle cramps, and diarrhoea. But these adverse consequences are uncommon.

Forms and Dosage

L-ornithine L-aspartate is sold in several forms like rapid melt granules, tablets and injection. In patients with advanced liver disease, the recommended daily dose for tablets is 9-18 grams for up to 3 months. Injection for the same comes with a recommended adult dose of 5-40 grams for up to 7 days.

How does L-ornithine L-aspartate work?

LOLA is what is known as a stable salt of the two constituent amino acids, L-ornithine and L-aspartate. L-ornithine stimulates the urea cycle finally resulting in loss of ammonia. L-ornithine L-aspartate actions lower blood ammonia levels and increase the levels of ornithine and aspartic acid in the body. Ammonia is then used to convert glutamate to glutamine by glutamine synthetase. As both a l-ornithine and l-aspartate are both substrates for glutamate transaminase, LOLA administration can result in increased glutamate levels. Ornithine and aspartic acid levels in the body are raised by L-ornithine L-aspartate. These amino acids aid in lowering blood levels of the poisonous toxin ammonia.

The Cost of L-ornithine L-aspartate

An online search for the wholesale price for sale of L-ornithine L-aspartate for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. The consumer in the USA has to pay USD 70 for a supply of 100g of L-ornithine-L-aspartate. The cost of this medicine varies widely in the developing world, as can be seen in India, where the same supply of 100g will cost between $7-$70.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of L-ornithine L-aspartate distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance L-ornithine L-aspartate suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of L-ornithine L-aspartate. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where L-ornithine L-aspartate is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers L-ornithine L-aspartate suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen L-ornithine L-aspartate Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.